Novartis Targeting India For Natural Drug Ingredients
This article was originally published in PharmAsia News
Executive Summary
India is a prime target for Novartis, the Swiss drug maker looking for biodiverse resources from which to produce drugs. The outgoing chairman of Novartis India said the parent company is looking at the seas, rain forests, fungi and micro-organisms that use natural ingredients to protect themselves. Peter Jager said a Novartis project in China is looking at fungi that contain an ingredient that fights cancer, and at a micro-organism in Thailand that grows on an insect. But Jager said India itself has a great potential for bioresources and is part of the Novartis research plan. (Click here for more